Los Angeles, CA10 Active Studies

Huntingtons Disease Clinical Trials in Los Angeles, CA

Find 10 actively recruiting huntingtons disease clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

10
Active Trials
9
Sponsors
39,694
Enrolling

Recruiting Huntingtons Disease Studies in Los Angeles

About Huntingtons Disease Clinical Trials in Los Angeles

Huntington's disease is an inherited condition that causes progressive degeneration of nerve cells in the brain, affecting movement, cognition, and behavior. It is caused by a mutation in the HTT gene. Current treatments manage symptoms, while gene-silencing therapies are being studied.

There are currently 10 huntingtons disease clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 39,694 participants. Research is being sponsored by CHDI Foundation, Inc., Incyte Corporation, Carl Backes, MD and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Huntingtons Disease Clinical Trials in Los Angeles — FAQ

Are there huntingtons disease clinical trials in Los Angeles?

Yes, there are 10 huntingtons disease clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What huntingtons disease treatments are being tested?

The 10 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for huntingtons disease.

Data updated September 29, 2026 from ClinicalTrials.gov